Rapidly generated virus specific T (R-MVST) cells
- Generic Name
- Rapidly generated virus specific T (R-MVST) cells
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Phase 1
Not yet recruiting
- Conditions
- Epstein-Barr VirusCytomegalovirus InfectionsAdenovirusBK Virus InfectionImmune Deficiency
- Interventions
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 18
- Registration Number
- NCT06926894
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
R-MVST Cells for Treatment of Viral Infections
Phase 1
Recruiting
- Conditions
- Cytomegalovirus InfectionsAdenovirusBK Virus InfectionEpstein-Barr Virus Infections
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 36
- Registration Number
- NCT05183490
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath